Adenosine A2A receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 5, 2001, Pages 791-796

  McPherson, John A ^a   Barringhaus, Kurt G ^a   Bishop, Gregory G ^a   Sanders, John M ^a   Rieger, Jayson M ^a   Hesselbacher, Sean E ^a   Gimple, Lawrence W ^a   Powers, Eric R ^a   Macdonald, Timothy ^a   Sullivan, Gail ^a   Linden, Joel ^a   Sarembock, Ian J ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Adenosine; Cell adhesion molecules; Endothelium; Leukocytes; Restenosis

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ATL 146 E; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY LIGATION; CONTROLLED STUDY; FEMALE; INFLAMMATION; MACROPHAGE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0035041314     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.5.791     Document Type: Article

References (38)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-124.
2. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol. 1998; 18:842-851.
3. Serrano CV, Ramires JAF, Venturinelli M, Arie S, D'Amico E, Zweier JL, Pileggi F, DaLuz PL. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. J Am Coll Cardiol. 1997;29:1276-1283.
4. Tanaka H, Sukhova GK, Swanson SJ, Clinton SK, Ganz P, Cybulsky MI, Libby P. Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation. 1993;88:1788-1803.
5. Malik AB, Lo SK. Vascular endothelial adhesion molecules and tissue inflammation. Pharmacol Rev. 1996;48:213-229.
6. Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol. 1994;76:5-13.
7. Ely SW, Berne RM. Protective effects of adenosine in myocardial ischemia. Circulation. 1992;85:893-904.
8. Smits GJ, McVey M, Cox BF, Perrone MH, Clark KL. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction. J Pharmacol Exp Ther. 1998; 286:611-618.
9. Lozza G, Conti A, Ongini E, Monopoli A. Cardioprotective effects of adenosine A1 and A2A receptor agonists in the isolated rat heart. Pharm Res. 1997;35:57-64.
10. Richter J. Effect of adenosine analogues and cAMP-raising agents on TNF-, GM-CSF, and chemotactic peptide-induced degranulation in single adherent neutrophils. J Leukoc Biol. 1992;51:270-275.
11. Hasko G, Szabo C, Nemeth Z, Kvetan V, Pastores SM, Vizi ES. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol. 1996;157:4634-4640.
12. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol. 1997;17:2238-2244.
13. Kumar A, Hoover JL, Simmons CA, Lindner V, Shebuski RJ. Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice. Circulation. 1997;96:4333-4342.
14. 2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am J Physiol. 1999;277:F404-F412.
15. 2A-selective adenosine receptor antagonist. Br J Pharmacol. 1995;115:1096-1102.
16. Bryant SR, Bjercke RJ, Erichsen DA, Rege A, Lindner V. Vascular remodeling in response to altered blood flow is mediated by fibroblast growth factor-2. Circ Res. 1999;84:323-328.
17. Leder LD. The selective enzymochemical demonstration of neutrophilic myeloid cells and tissue mast cells in paraffin stains. Klin Wochenschr. 1964;42:533-536.
18. Green SA, Setiadi H, McEver RP, Kelly RB. The cytoplasmic domain of P-selectin contains a sorting determinant that mediates rapid degradation in lysosomes. J Cell Biol. 1994;124:435-448.
19. Russell HK. A modification of Movat's pentachrome stain. Arch Pathol. 1972;94:187-191.
20. Hirosumi J, Nomoto A, Ohkubo Y, Sekiguchi C, Mutoh S, Yamaguchi I, Aoki H. Inflammatory responses in cuff-induced atherosclerosis in rabbits. Atherosclerosis. 1987;64:243-254.
21. Kling D, Holzschuh T, Betz E. Recruitment and dynamics of leukocytes in the formation of arterial intimal thickening: a comparative study with normo- and hypercholesterolemic rabbits. Atherosclerosis. 1993;101:79-96.
22. Gimbrone MA, Nagel T, Topper JM. Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J Clin Invest. 1997; 100:61S-65S.
23. Krams R, Wentzel JJ, Oomen JAF, Vinke R, Schuurbiers JCH, de Feyter PJ, Serruys PW, Slager CJ. Evaluation of endothelial shear stress and 3D geometry as factors determining the development of atherosclerosis and remodeling in human coronary arteries in vivo. Arterioscler Thromb Vasc Biol. 1997;17:2061-2065.
24. Walpola PL, Gotlieb AI, Cybulsky MI, Langille BL. Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. Arterioscler Thromb Vasc Biol. 1995;15:2-10.
25. Cybulsky MI, Gimbrone MA. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991;251: 788-791.
26. Chappell DC, Varner SE, Nerem RM, Medford RM, Alexander RW. Oscillatory shear stress stimulates adhesion molecule expression in cultured human endothelium. Circ Res. 1998;82:532-539.
27. De Keulenaer GW, Chappell DC, Ishizaka N, Nerem RM, Alexander RW, Griendling KK. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state. Circ Res. 1998;82: 1094-1101.
28. Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Takabatake Y. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1996;28:1127-1133.
29. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 1992;359: 848-851.
30. Barron MK, Lake RS, Buda AJ, Tenaglia AN. Intimal hyperplasia is attenuated by blocking selectins. Circulation. 1997;96:3587-3592.
31. Braun M, Pietsch P, Zepp A, Schrör K, Baumann G, Felix SB. Regulation of tumor necrosis factor-alpha and interleukin-1 beta induced adhesion molecule expression in human vascular smooth muscle cells by cAMP. Arterioscler Thromb Vasc Biol. 1997;17:2568-2575.
32. Ollivier V, Parry GCN, Cobb RR, de Prost D, Mackman N. Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem. 1996;271: 20828-20835.
33. Sexl V, Mancusi G, Baumgartner-Parzer S, Schutz W, Freissmuth M. Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoreceptors. Br J Pharmacol. 1995;114: 1577-1586.
34. 2A-adenosine receptor in primary human endothelial cells. J Biol Chem. 1997; 272:5792-5799.
35. Wollner A, Wollner S, Smith JB. Acting via A2 receptors, adenosine inhibits the upregulation of Mac-1 (Cd11b/CD18) expression on FMLP-stimulated neutrophils. Am J Respir Cell Mol Biol. 1993;9:179-185.
36. 2 receptors. J Immunol. 1992;148:2201-2206.
37. Minamino T, Kitakaze M, Asanuma H, Tomiyama Y, Shiraga M, Sato H, Ueda Y, Funaya H, Kuzuya T, Matsuzawa Y, et al. Endogenous adenosine inhibits P-selectin-dependent formation of coronary thromboemboli during hypoperfusion in dogs. J Clin Invest. 1998;101:1643-1653.
38. 2A receptors. Trends Pharmacol Sci. 1996;17:364-372.